Bioavailability and absorption of ingredients is an important issue for many dietary supplements in the market. The higher the bioavailability of a nutrient, the more that nutrient can be absorbed and benefit the body. For the human body to receive maximum benefits from lipophilic actives (fat-soluble ingredients)—such as Lutein, Resveratrol, Curcumin, and Omega-3s—they must be surrounded with an emulsifier to make them more bioavailable and absorbable.
AquaCelle® is a trademark of Pharmako Biotechnologies Pty Ltd.
AquaCelle® is a lipid based formulation that self-assembles into a micellar colloidal delivery system in aqueous environments (such as the stomach) at body temperature. These micelles are what envelop fat-soluble ingredients, helping their benefits to be absorbed more fully into the body.
The body has its own built-in capacity to make fat-soluble ingredients absorbable. Using the liver to form bile acids and then bile salts, the body then secretes these salts to surround molecules of fat-soluble ingredients to allow them to be absorbed by the small intestine. The formation of micelles is time-consuming and waits on bile salts to form, be secreted, and form micelles before each ingredient can be properly and beneficially absorbed, leaving room for fat-soluble nutrients to be damaged by stomach acids while waiting.
AquaCelle® is designed to more efficiently create these micelles, delivering better absorption and a more efficacious finished product for the consumer.
Technology Fuels Omega-3 Growth
Aquacelle Delivery Technology Shown to Improve Omega 3 Absorption
Our award winning LipiSperse® is an advanced cold water dispersion technology(CWD). Allowing solid lipophilic active ingredients with otherwise relatively low bioavailability & poor solubility in water, to be easily dispersed in cold water, thereby increasing their bioavailability and uptake in the body.
LipiSperse® is a trademark of Pharmako Biotechnologies Pty Ltd.
Pharmako's Compressible Powdered Oils (CPOs) are an ingenious material development that allow oily active ingredients to be included in tablet & powder formulations without leaching of the oil.
Pharmako's CPO Astaxanthin extends the formatting range of this novel ingredient. With our development, astaxanthin is now able to be utilised in tablet & powder formulations with a high 4% concentration and superior stability.
Pharmako's CPO Lavender is a progressive material development that allows lavender oil to be converted into a powder with a 50% loading. The powder is not sensitive to temperature and pressure, with a high linalool and linalyl acetate concentration.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.